This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products.
Will Cost Headwinds Dampen Danaher's (DHR) Q2 Earnings?
by Zacks Equity Research
While impressive segmental performances are expected to have aided Danaher's (DHR) Q2 performance, high costs might have impeded the bottom line.
Danaher (DHR) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $265.30, moving +0.58% from the previous trading session.
HTHIY vs. DHR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
HTHIY vs. DHR: Which Stock Is the Better Value Option?
Danaher (DHR) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed at $255.51 in the latest trading session, marking a -0.98% move from the prior day.
Danaher (DHR) Stock Moves -1.77%: What You Should Know
by Zacks Equity Research
In the latest trading session, Danaher (DHR) closed at $251.88, marking a -1.77% move from the previous day.
The Zacks Analyst Blog Highlights Tesla, Broadcom, Anthem, Oracle and Danaher
by Zacks Equity Research
Tesla, Broadcom, Anthem, Oracle and Danaher have been included in this Analyst Blog.
Top Stock Reports for Tesla, Broadcom & Anthem
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Tesla, Inc. (TSLA), Broadcom Inc. (AVGO), and Anthem, Inc. (ANTM).
Danaher (DHR) Exhibits Bright Prospects, Headwinds Persist
by Zacks Equity Research
Danaher (DHR) gains from solid demand for its products, acquired assets and shareholder-friendly policies. However, escalating costs and high debt levels remain concerns.
Danaher (DHR) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed at $245.91 in the latest trading session, marking a +0.84% move from the prior day.
Danaher (DHR) Stock Moves -1.67%: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $240.85, moving -1.67% from the previous trading session.
MARUY or DHR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MARUY vs. DHR: Which Stock Is the Better Value Option?
Danaher (DHR) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $263.74, moving -0.87% from the previous trading session.
Why Is ITT (ITT) Down 5.5% Since Last Earnings Report?
by Zacks Equity Research
ITT (ITT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MARUY vs. DHR: Which Stock Is the Better Value Option?
by Zacks Equity Research
MARUY vs. DHR: Which Stock Is the Better Value Option?
The Zacks Analyst Blog Highlights Adobe, Danaher, Equinor, Advanced Micro Devices, and Automatic Data Processing
by Zacks Equity Research
Adobe, Danaher, Equinor, Advanced Micro Devices, and Automatic Data Processing are part of Zacks Top Analyst Blog.
Top Analyst Reports for Adobe, Danaher, Equinor & Others
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Adobe Inc. (ADBE), Danaher Corporation (DHR), and Equinor ASA (EQNR).
Top Analyst Reports for Alphabet, Amazon & Chevron
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Amazon.com, Inc. (AMZN), and Chevron Corporation (CVX).
All You Need to Know About Danaher (DHR) Rating Upgrade to Buy
by Zacks Equity Research
Danaher (DHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Danaher's (DHR) Q1 Earnings & Revenues Beat, Increase Y/Y
by Zacks Equity Research
Danaher's (DHR) first-quarter 2022 revenues increase 12% year over year driven by impressive performance across its segments.
Danaher (DHR) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Danaher (DHR) delivered earnings and revenue surprises of 4.15% and 1.88%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights UnitedHealth Group, Danaher, Wells Fargo, Vertex Pharmaceuticals and Canadian Pacific Railway
by Zacks Equity Research
UnitedHealth Group, Danaher, Wells Fargo, Vertex Pharmaceuticals and Canadian Pacific Railway have been included in this Analyst Blog.
Q1 Scorecard and Analyst Reports for UnitedHealth, Danaher & Wells Fargo
by Sheraz Mian
Today's Research Daily features Q1 earnings season scorecard and fresh reports on UnitedHealth(UNH), Danaher (DHR), Wells Fargo (WFC) & others.
Danaher (DHR) to Post Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Danaher's (DHR) Q1 earnings are likely to have benefited from better-than-expected performances across its Diagnostics and Life Sciences segments. Cost inflation might have dragged its margins.
5 Perfect Earnings Charts
by Tracey Ryniec
It's not easy to beat every quarter for 5 years, especially during a pandemic. These 5 companies are earnings all-stars.
SSUMY vs. DHR: Which Stock Is the Better Value Option?
by Zacks Equity Research
SSUMY vs. DHR: Which Stock Is the Better Value Option?